Company Quick10K Filing
Westmoreland Coal
10-Q 2018-09-30 Filed 2018-11-01
10-Q 2018-06-30 Filed 2018-08-06
10-Q 2018-03-31 Filed 2018-05-04
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-10-31
10-Q 2017-06-30 Filed 2017-08-04
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-29
10-Q 2016-09-30 Filed 2016-11-01
10-Q 2016-06-30 Filed 2016-08-02
10-Q 2016-03-31 Filed 2016-05-10
10-K 2015-12-31 Filed 2016-03-14
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-07-31
10-Q 2015-03-31 Filed 2015-04-28
10-K 2014-12-31 Filed 2015-03-06
10-Q 2014-09-30 Filed 2014-10-28
10-Q 2014-06-30 Filed 2014-07-31
10-Q 2014-03-31 Filed 2014-04-25
10-K 2013-12-31 Filed 2014-02-28
10-Q 2013-09-30 Filed 2013-10-25
10-Q 2013-06-30 Filed 2013-07-26
10-Q 2013-03-31 Filed 2013-04-30
10-K 2012-12-31 Filed 2013-03-12
10-Q 2012-09-30 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-08
10-K 2011-12-31 Filed 2012-03-13
10-Q 2011-09-30 Filed 2011-11-08
10-Q 2011-06-30 Filed 2011-08-05
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-03-11
10-Q 2010-09-30 Filed 2010-11-05
10-Q 2010-06-30 Filed 2010-08-09
10-Q 2010-03-31 Filed 2010-05-10
10-K 2009-12-31 Filed 2010-03-12
8-K 2019-03-15
8-K 2019-03-14
8-K 2019-03-02
8-K 2019-01-10
8-K 2019-01-02
8-K 2018-12-18
8-K 2018-12-12
8-K 2018-10-10
8-K 2018-10-09
8-K 2018-10-05
8-K 2018-09-26
8-K 2018-09-18
8-K 2018-09-11
8-K 2018-08-16
8-K 2018-08-01
8-K 2018-06-28
8-K 2018-06-11
8-K 2018-05-25
8-K 2018-05-21
8-K 2018-04-20
8-K 2018-04-13
8-K 2018-04-02
8-K 2018-03-29
8-K 2018-03-23
8-K 2018-03-12
8-K 2018-03-07

Westmoreland Coal Financials

WLB Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
ForeverGreen (FVRG) 7 77% 43.6 -50% 3 12 12 9 -2 0 8
Castle AM (CTAM) 7 0% 45.0 -8% 347 382 434 0 -29 6 262
Sonic Foundry (SOFO) 7 73% -4.2 -24% 15 21 35 26 -4 -2 9
RXI Pharmaceuticals (RXII) 7 0% -0.5 -194% 4 2 0 0 -7 -7 4
Ethema Health (GRST) 7 0% -1.2 -32% 23 33 1 0 -8 -6 7
Vivos (RDGL) 7 0% -7.6 -561% 0 1 0 0 -1 -1 7
Mikros Systems (MKRS) 7 61% -32.0 -4% 3 1 5 3 -0 -0 5
Pressure Biosciences (PBIO) 7 41% -1.9 -331% 2 12 2 1 -8 -4 7
MGT Capital Investments (MGTI) 7 -31% -0.6 -144% 5 2 0 -0 -8 -8 5
International Stem Cell (ISCO) 7 62% -5.0 -19% 8 5 7 4 -2 -1 7
Star Gold (SRGZ) 7 -29.3 -31% 1 0 0 0 -0 -0 7
Westmoreland Coal (WLB) 7 22% -73.7 -15% 1,468 2,191 1,265 282 -219 -13 973
Vaso (VASO) 7 54% -5.8 -7% 46 43 52 28 -3 -1 6
Scientific Industries (SCND) 7 43% 6.9 5% 9 3 10 4 0 1 6
Vitality Biopharma (VBIO) 7 0% -0.2 -324% 4 2 0 0 -14 -14 3
Avant Diagnostics (AVDX) 7 -3.1 -52% 5 3 0 0 -3 -2 7
Video Display (VIDE) 7 25% -52.2 -3% 10 5 14 3 -0 -0 6
Boston Therapeutics (BTHE) 7 0% -4.7 -207% 1 6 0 0 -2 -1 7
China Xuefeng Environmental (CXEE) 7 59% -1.6 6% 88 20 14 8 5 10 -16
Textmunication Holdings (TXHD) 7 61% -2.2 -559% 1 1 1 0 -3 -3 7

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash42433150475432413645616241124145336292318362960755844103127121152
Accounts Receivable404746565568606057676665130139143154137147134150143140141131133146104957989
Inventory262626373636384040394035153114134134139124122143130129126120121110107123137110
PP&E7167187258698788918979039169209369511,2711,2471,4561,4861,5111,5081,2671,4661,4731,4801,6181,6351,6481,6717421,6581,2401,253
Assets7727697599559489719369439349409471,4071,5841,5791,8301,8301,7781,7281,5021,7711,7431,7201,5851,5111,4591,4351,3891,6371,4581,468
Accounts Payable
Long-Term Debt4053993713333263213487808148019981,0621,0501,0641,0571,1751,1811,1661,1471,1271,1081,1011,0761,0671,1111,118
Liabilities9539431,0091,2041,2071,2241,2221,2301,2151,2201,1351,6131,8441,8432,1792,2182,2002,2172,1042,3212,3162,3012,2752,2332,2262,2092,1332,1262,1442,191
Stockholders' Equity-174-167-242-240159153143143142143140135391278-365-402-434-491-603-550-572-580-688-720-764-771-739-484-676-711
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue112132129146133161159161163177174180288338310371349350341355356371396340323358364296276329
Cost of Revenue91100104111123117127130131138136139249286229302285293265274290279314285272280260225227271
Gross Profit2132263510443231323938423952817063577681669282555178104714958
R&D
SG&A91012141612311223121413292432272929283232311430302831343940
Tax-0-000121342-5743-3274-33-48-0-22-0-1-0-4-0-10
Net Income-73-11-0816-12797-562735-41-12-37-47-10830-26-9-24-37-51-1934-20-191-41
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating10111311-901232114242230-19281221092518194768-1111193-9-3149
Cash Investing-1-18-103-8109-12119-9-6-1610816-88-11-14-23-23-1317-23-839-7-15-6-8-2-12
Cash Financing-7-5109-6-14010435-9-8-6451-10941-3350-148-8107-8-31-28-23-22-9-29-1027-6